Table 2.
A. | ||||
---|---|---|---|---|
Pathology | Odds Ratio (95% CI) | Wald χ2 | Significance | |
Lewy Body (Braak) | 0.002* | |||
Braak 4a | 1.68 (0.16 – 18.08) | 0.670 | ||
Braak 5a | 7.46 (0.80 – 69.49) | 0.078 | ||
Braak 6a | 35.18 (3.21 – 385.64) | 0.004* | ||
ADNC | 0.818 | |||
Lowb | 1.33 (0.46 – 3.89) | 0.601 | ||
Intermediateb | 2.34 (0.42 – 13.11) | 0.335 | ||
Highb | † | 0.999 | ||
CAA | 0.427 | |||
Minimalb | 0.35 (0.02 – 6.48) | 0.478 | ||
Mildb | 0.51 (0.15 – 1.72) | 0.280 | ||
Moderateb | 0.11 (0.01 – 1.10) | 0.061 | ||
Severeb | 0.47 (0.03 – 7.32) | 0.590 | ||
Arteriolosclerosis | 0.436 | |||
Mildb | 2.67 (0.14 – 52.01) | 0.518 | ||
Moderateb | 1.83 (0.09 – 36.77) | 0.694 | ||
Severeb | 13.11 (0.30 – 575.3) | 0.182 | ||
B. | ||||
Pathology | Odds Ratio (95% CI) | Wald χ2 | Significance | |
β-amyloid | 2.257 | 0.521 | ||
Score 1c | 2.64 (0.731 – 9.51) | 2.196 | 0.138 | |
Score 2c | 1.37 (0.33 – 5.67) | 0.192 | 0.662 | |
Score 3c | 1.53 (0.13 – 17.44) | 0.116 | 0.733 | |
NFT | 0.852 | 0.837 | ||
Score 1c | 0.39 (0.045 – 3.34) | 0.746 | 0.388 | |
Score 2c | 0.56 (0.043 – 7.36) | 0.194 | 0.659 | |
Score 3c | † | 3.0 x 10−6 | 0.999 | |
Neuritic plaques | 1.711 | 0.634 | ||
Score 1c | 6.80 (0.39 – 120.1) | 1.711 | 0.191 | |
Score 2c | † | 4.0 x 10−6 | 0.998 | |
Score 3c | † | 1.65 x 10−10 | 0.999 |
ADNC = Alzheimer disease neuropathologic change, CAA = Cerebral amyloid angiopathy, NFT = neurofibrillary tangles
denotes significance at p = 0.05.
Odds ratio with 95% CI could not be calculated.
Contrast with Braak stage 3.
Contrast with “none”.
Contrast with score 0.